Latest TGen Drug Development Stories
Seattle’s own Cancer Research And Biostatistics (CRAB), and Translational Drug Development (TD2) in Scottsdale, would like to jointly announce CRAB’s assumption of responsibility for the PCRT,
Will oversee Virginia G.
MPI’s Drug Response Predictor (DRP) can generate new and unique clinically relevant gene signatures - a strong complementary drug development tool; TD2 is an oncology drug development company
The Tableau TD2, a popular forensic disk imaging system was compared to CyanLine’s Fast Disk Acquisition System (FDAS) to see which system was faster and more cost-effective; FDAS captures information
Leading forensic imaging systems Tableau TD2 and CyanLine Fast Disk Acquisition System (FDAS) competed side by side to see which system is the fastest and most cost-effective – Results prove
The Side-Out Foundation's breast cancer pilot study, led by the Translational Genomics Research Institute (TGen), Translational Drug Development (TD2) and Scottsdale Healthcare, has shown that cancer patients do better when their treatment is guided by molecular profiling.
The new TRC-TD2 partnership will allow investigators the ability to test the efficacy of new radiation techniques with potential new drugs. SCOTTSDALE, Ariz.
- The word or words serving to define another word or expression, as in a dictionary entry.